Curexo Inc (060280) - Total Assets

Latest as of September 2025: ₩103.65 Billion KRW ≈ $70.24 Million USD

Based on the latest financial reports, Curexo Inc (060280) holds total assets worth ₩103.65 Billion KRW (≈ $70.24 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore debt repayment capacity of Curexo Inc to assess how comfortably operating cash covers total debt obligations.

Curexo Inc - Total Assets Trend (2006–2024)

This chart illustrates how Curexo Inc's total assets have evolved over time, based on quarterly financial data. See 060280 total equity for net asset value and shareholders' equity analysis.

Curexo Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Curexo Inc's total assets of ₩103.65 Billion consist of 85.7% current assets and 14.3% non-current assets.

Asset Category Amount (KRW) % of Total Assets
Cash & Equivalents ₩13.88 Billion 0.0%
Accounts Receivable ₩15.01 Billion 14.6%
Inventory ₩37.11 Billion 36.2%
Property, Plant & Equipment ₩7.85 Billion 7.7%
Intangible Assets ₩636.13 Million 0.6%
Goodwill ₩0.00 0.0%

Asset Composition Trend (2006–2024)

This chart illustrates how Curexo Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Curexo Inc market cap and net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Curexo Inc's current assets represent 85.7% of total assets in 2024, an increase from 0.0% in 2006.
  • Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 7.3% in 2006.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 25.0% in 2006.
  • Asset Diversification: The largest asset category is inventory at 36.2% of total assets.

Curexo Inc Competitors by Total Assets

Key competitors of Curexo Inc based on total assets are shown below.

Company Country Total Assets
Gimat Magazacilik Sanayi ve Ticaret AS
IS:GMTAS
Turkey TL5.51 Billion
Seouleaguer Co. Ltd
KQ:043710
Korea ₩126.21 Billion
HMM Co Ltd
KO:011200
Korea ₩31.98 Trillion
KakaoBank Corp
KO:323410
Korea ₩77.66 Trillion
PSK Inc
KQ:319660
Korea ₩608.69 Billion
Shinsegae
KO:004170
Korea ₩15.48 Trillion
HYBE Co. Ltd
KO:352820
Korea ₩5.66 Trillion
Cheil Worldwide
KO:030000
Korea ₩3.43 Trillion

Curexo Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 11.22 12.71 11.46
Quick Ratio 6.10 7.37 5.24
Cash Ratio 0.00 0.76 0.00
Working Capital ₩81.66 Billion ₩84.20 Billion ₩35.66 Billion

Curexo Inc - Advanced Valuation Insights

This section examines the relationship between Curexo Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 7.60
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) -4.5%
Total Assets ₩102.58 Billion
Market Capitalization $186.50 Million USD

Valuation Analysis

Below Book Valuation: The market values Curexo Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Curexo Inc's assets decreased by 4.5% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Curexo Inc (2006–2024)

The table below shows the annual total assets of Curexo Inc from 2006 to 2024.

Year Total Assets Change
2024-12-31 ₩102.58 Billion
≈ $69.52 Million
-4.46%
2023-12-31 ₩107.37 Billion
≈ $72.76 Million
+9.12%
2022-12-31 ₩98.40 Billion
≈ $66.68 Million
+60.50%
2021-12-31 ₩61.31 Billion
≈ $41.55 Million
+25.42%
2020-12-31 ₩48.88 Billion
≈ $33.12 Million
+3.72%
2019-12-31 ₩47.13 Billion
≈ $31.94 Million
-35.74%
2018-12-31 ₩73.34 Billion
≈ $49.70 Million
-2.93%
2017-12-31 ₩75.55 Billion
≈ $51.20 Million
-3.45%
2016-12-31 ₩78.25 Billion
≈ $53.03 Million
+33.47%
2015-12-31 ₩58.63 Billion
≈ $39.73 Million
+45.35%
2014-12-31 ₩40.34 Billion
≈ $27.33 Million
+2.02%
2013-12-31 ₩39.54 Billion
≈ $26.79 Million
-23.12%
2012-12-31 ₩51.43 Billion
≈ $34.85 Million
-41.60%
2011-12-31 ₩88.07 Billion
≈ $59.68 Million
+226.01%
2010-12-31 ₩27.01 Billion
≈ $18.31 Million
-13.27%
2009-12-31 ₩31.15 Billion
≈ $21.11 Million
-34.70%
2008-12-31 ₩47.70 Billion
≈ $32.32 Million
+18.04%
2007-12-31 ₩40.41 Billion
≈ $27.38 Million
+7.03%
2006-12-31 ₩37.75 Billion
≈ $25.59 Million
--

About Curexo Inc

KQ:060280 Korea Food & Drug Retailing
Market Cap
$186.50 Million
₩275.20 Billion KRW
Market Cap Rank
#16731 Global
#605 in Korea
Share Price
₩8250.00
Change (1 day)
+13.64%
52-Week Range
₩7260.00 - ₩20350.00
All Time High
₩24400.00
About

Curexo Inc. engages in the development and sale of medical devices in Korea and internationally. Its products include ROBIN, a robot system that guides needle path induring CT-guided interventional procedure; Baidy, a medical device that assists labor by increasing intrauterine pressure which helps natural childbirth; artificial joint surgical robot; and Gait rehabilitation robot. The company als… Read more